Crinetics Pharmaceuticals, Inc. Cash and Restricted Cash
Crinetics Pharmaceuticals, Inc. (CRNX) had Cash and Restricted Cash of $56.30 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-03
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $56.30M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $115.14M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $102.34M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $112.20M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $56.30M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $115.14M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $102.34M 10-Q · filed 2026-08-03 |
| 2025-09-30 | $112.20M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $55.03M 10-Q · filed 2026-08-03 |
| 2025-03-31 | $95.87M 10-Q · filed 2026-05-07 |
| 2024-12-31 | $265.85M 10-Q · filed 2026-08-03 |
| 2024-09-30 | $318.57M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $303.46M 10-Q · filed 2025-08-07 |
| 2024-03-31 | $397.22M 10-Q · filed 2025-05-08 |
| 2023-12-31 | $56.20M 10-K · filed 2026-02-26 |
| 2023-09-30 | $144.09M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $40.85M 10-Q · filed 2024-08-08 |
| 2023-03-31 | $42.49M 10-Q · filed 2024-05-09 |
| 2022-12-31 | $33.97M 10-K · filed 2026-02-26 |
| 2022-09-30 | $32.21M 10-Q · filed 2023-11-07 |
| 2022-06-30 | $62.79M 10-Q · filed 2023-08-08 |
| 2022-03-31 | $146.05M 10-Q · filed 2023-05-09 |
| 2021-12-31 | $201.19M 10-K · filed 2025-02-27 |
| 2021-09-30 | $162.04M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $179.27M 10-Q · filed 2022-08-12 |
| 2021-03-31 | $106.08M 10-Q · filed 2022-05-12 |
| 2020-12-31 | $93.59M 10-K · filed 2024-02-28 |
| 2020-09-30 | $118.32M 10-Q · filed 2021-11-05 |
| 2020-06-30 | $161.31M 10-Q · filed 2021-08-10 |
| 2020-03-31 | $51.42M 10-Q · filed 2021-05-06 |
| 2019-12-31 | $40.83M 10-K · filed 2023-02-28 |
| 2019-09-30 | $67.08M 10-Q · filed 2020-11-06 |
| 2019-06-30 | $60.22M 10-Q · filed 2020-08-07 |
| 2019-03-31 | $63.33M 10-Q · filed 2020-05-08 |
| 2018-12-31 | $45.47M 10-K · filed 2022-03-30 |
| 2018-09-30 | $170.15M 10-Q · filed 2019-11-12 |
| 2018-06-30 | $68.91M 10-Q · filed 2019-08-13 |
| 2018-03-31 | $74.24M 10-Q · filed 2019-05-13 |
| 2017-12-31 | $14.19M 10-K · filed 2021-03-30 |
| 2017-09-30 | $9.86M 10-Q · filed 2018-11-13 |
| 2017-06-30 | $12.33M 10-Q · filed 2018-08-30 |
| 2016-12-31 | $12.15M 10-K · filed 2020-03-09 |
| 2015-12-31 | $17.86M 10-K · filed 2019-03-13 |